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If anyone dies – the question is when and what the cause is, and how the quality of life has been. Patients 
with bipolar disorder and patients with schizophrenia, most often comprising the group of patients 
defined as severe mental illness (SMI), have an increased mortality rate in comparison to the general 
population (1,2). Despite differences between disorders there are similar patterns of increasing relative 
mortality rates over time for bipolar disorder and schizophrenia (2). Current data supports the largest  gap 
in mortality rate in younger persons with SMI as compared to the background population, as in this age 
group death is a relatively uncommon event in the general population (1). Over the last half a century, a 
significant increase in life expectancy has been observed, most likely as a result of earlier diagnosis and 
improved treatment for diseases eventually leading to death from natural causes. The benefits have been 
most pronounced in patients without SMI, as compared to patients with SMI, but improvements in terms 
of mortality have likely also occurred in patients with SMI, although some data support a general lowering 
in age at death for patients with schizophrenia (3). Regarding deaths from unnatural causes, especially 
suicide, a decrease has occurred over the last decades in patients with SMI (3), which has naturally 
resulted in a relatively larger proportion of deaths occurring because of natural causes. 
In a randomized trial, combined treatment consisting of optimized pharmacological interventions, 
individual and group psychoeducation, the possibility of psychotherapeutic interventions and a high 
knowledge base for the treatment of bipolar disorders was shown to be superior to treatment as usual 
(4). Here, the same clinicians and nurses often treat patients throughout the duration of the outpatient 
program, thereby establishing a therapeutic relationship, which increases the likelihood of early 
intervention when the patient observes a negative change in mental state. Even though improvement of 
the mental disorder per se leads to better quality of life and indirectly may reduce the occurrence of 
somatic disease through changes in lifestyle and improved patient awareness of somatic symptoms, more 
needs to be done. The team of people supporting patients with SMI are most often composed of 
multidisciplinary psychiatric specialists, e.g. psychiatrists, psychologists and nurses, but they often lack 
sufficient knowledge of somatic diseases, which obviously leads to less focus and poorer management of 
these diseases. Thus their focus on the mental problems carries an inherent risk of these overshadowing 
the possible symptoms of somatic diseases. 
Psychiatric patients can be referred to somatic hospital-based care or to their general practitioner (GP) for 
further diagnostic procedures, for treatment of somatic diseases or for treatment of somatic risk factors. 
Lack of attendance for outpatient appointments is a problem in most settings, but is likely to be more 
problematic in patients with SMI across settings, including the somatic outpatient settings. If a possible 
risk factor for somatic disease, e.g. increased cholesterol or hypertension, is identified during routine 
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high risk of non-attendance. In this model, the responsibility for establishing contact and getting 
treatment is laid upon the patient. Several interventions have been proposed to minimize these problems, 
e.g. combining somatic and psychiatric healthcare  with both psychiatric and somatic treatment 
conducted by one treatment team nested in psychiatry (4). Such teams would be beneficial for most 
patients with SMI, but would probably mainly treat minor physical issues as seen from the perspective of 
internal medicine consultants, which could make it difficult to attract professionals to these positions. 
In cardiology and neurology, myocardial infarction and stroke are associated with an increased risk of 
affective disorders, especially depression, and treatment outcomes for the somatic disorders correlate 
negatively with the presence of a psychiatric disorder. As seen in psychiatry, albeit the other way around, 
the immediate somatic disorder may obscure possible mental symptoms or disorders, which for that 
reason may be unidentified and therefore left untreated. 
In other fields of medicine, a multi-specialty team of experts is typically involved in the treatment of 
patients with severe life threatening illnesses. In patients diagnosed with cancer, oncologists, surgeons, 
radiologist and internalists all join forces to treat the patient most efficiently. The member’s knowledge 
base and the patient population define the teams who meet regularly, with no other set agenda than 
discussing new patients and problems encountered. The latter might be of extraordinary importance as 
this could perhaps result in a lower threshold for discussing specific patients as compared to an approach 
where patients are only discussed when a meeting is called. Neurologists, cardiologists, endocrinologists 
and psychiatrists, constituting a natural group or team of specialists based on relevant and common 
psychiatric and somatic co-morbidities could adopt a similar model. Psychiatrists could be advised 
concerning a multitude of somatic conditions, e.g. treatment of hypertension, dyslipidemia, thyroid 
dysfunction or tremors whereas the cardiologist or neurologist might need advice on diagnosing or 
treating affective or psychiatric disorders in general. In this model, all attending clinicians would have a 
possible gain and the group would have a common aim. This could ensure attendance from all involved, 
and would result in a smaller impact on the clinical life of consultants attending these meetings, as their 
main function would still be within their own area of expertise. The team members would be able to 
advice in regard to specific treatment choices, diagnostic procedures and follow-up with their own 
knowledge base, and would naturally see patients as needed. Furthermore, the model would most likely 
result in more attention being paid towards co-morbidities.
Patients with SMI have an increased mortality rate as compared to the general population, mainly as a 
result of excess deaths due to somatic diseases, and in a theoretical model adjusting for all diagnosed 
somatic diseases, patients with schizophrenia have been known to have a mortality rate twice the 
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mortality rate associated with SMI, assuming similar findings for patients with bipolar disorder, is not only 
associated with the specific, diagnosed, somatic co-morbidities, but is also associated to the overall 
burden of having a severe mental illness. SMI is associated with a poorer social network, lower socio-
economic class, lower educational level, cognitive deficits, a higher rate of substance abuse and 
psychiatric symptoms overshadowing somatic symptoms and disorders in both somatic and psychiatric 
care. Several of these factors could lead to a longer latency to request somatic treatment when 
experiencing somatic symptoms or simply to non-detection of somatic diseases. 
To deal with the burgeoning excess mortality in patients with SMI, it is clear that a multifaceted approach 
is needed. Within such an approach, psychiatric care still is essential to reduce psychiatric symptoms and 
to prevent their reemergence, by optimizing psychoeducation, psychological treatment and 
pharmacotherapy. Such efforts have already resulted in reduced rates of suicide over the latest decades, 
and will be even more essential in the future (3). However, even though focus on physical health has been 
growing over the recent years, new strategies in managing patients with SMI are obviously needed. The 
model proposed here; developing multi-specialty teams comprising psychiatry and other fields of 
medicine, based on mutually relevant co-morbidities, will provide patients with both SMI and patients 
with primarily somatic disorders the advantage of specialized treatment of their main conditions as well 
as resulting in specialized treatment of their somatic and/or psychiatric co-morbidity. Patients will not 
need to leave the established main therapeutic relationship ensuring ongoing attendance. 
The proposed model is not necessarily a one size fits all, as the functional capacity of patients varies. 
Some might be better served by contacting the GP themselves, but in the proposed model patients will 
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